Abcam establishes a direct service for ANZ
Protein research tool provider Abcam has established a direct service to Australia and New Zealand. Researchers can now source products and technical support directly from the UK-based company, rather than through distributors.
Abcam manufactures high-performance products such as primary and secondary antibodies, biochemicals, proteins, peptides, lysates and immunoassays. In addition, the company offers technical support and up-to-date datasheets. Such support will now be offered directly to ANZ customers, as will improved product delivery times.
“I’m delighted that we can offer an enhanced service to our customers in Australia and New Zealand,” said Abcam Commercial Director Philippe Cotrel.
“A direct service will enable us to develop closer relationships with our customers and ensure we are fully meeting their research needs.”
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
Australia announces $7.2m diphtheria outbreak response package
To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...
MV Hondius passengers return to Australia under strict infection control measures
The Australian CDC has provided an update on hantavirus risk to Australians and infection...
